AzTrials
AzTrials

SleepNCT06230094

Effect of 8 Weeks Moderate & High Intensity Training on Cognitive Functions and Sleep of Female Students

A study testing moderate intensity and high intensity in people with Sleep and Cognition, run by Riphah International University at 1 site in Pakistan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

this study aims to assess ther effectiveness of moderate \& high intensity training on cognitive functions and sleep of female students Read more about this study

Who is it for?
Ages 18 to 25 years, women onlyHealthy volunteers can take part
Conditions the study is for
Sleep, Cognition
What is being tested?
moderate intensity and high intensity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 sitePakistan
Study dates
1 Aug 2023to May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • female students
  • age between 18- 25

Who cannot join

  • History of trauma/ injury
  • mental illness
  • physical deformity
  • infection,fever

Trial locations and contacts

1 site in 1 country.

Pakistan1 site, 1 recruiting
  • Sargodha institute of health sciences

    Sargodha, Punjab Province, 40100

    Waqar Ahmed, PHD, 0333-5348846, waqar.ahmed@riphah.edu.pk

    Tabinda Kanwal, DPT, 03130565718, tabindakanwal25@gmail.com

    Recruiting

Other trials in Pakistan

About this study

this study aims to assess ther effectiveness of moderate \& high intensity training on cognitive functions and sleep of female students

Read the detailed description

In group A for moderate intensity training brisk walk will be performed(HR will be between 50%- 60% of maxHR).

warmup exercise will be performed to achieve 50%HR and then brisk walk will be performed till she reaches 60%HR.

This protocol will be followed for 5days per week. In group B for high intensity training skipping rope will performed (HR will be between 70%-85% of maxHR).

warmup exercise will be performed to achieve 70%HR and then skipping rope will be performed till she reaches 85%HR.

This protocol will be followed for alternative 3days per week.

Conditions
Sleep, Cognition
Being tested
moderate intensity, high intensity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • moderate intensityOther

    Arm Circles, Leg Swings, Lunges, brisk walk

  • high intensityOther

    Arm circles, Leg swings, Lunges, skipping rope

Study groups in NCT06230094
Study groupRoleWhat they receive
Group A ( moderate intensity training)Experimentalwarm up protocol to reach maxHR 50% than moderate intensity exercise. Group A will be given moderate intensity exercise i.e brisk walk will be performed.(HR will be between 50-60%).
Receives: Other: moderate intensity
Group B( high intensity training)Experimentalwarm up protocol to achieve 70% of maxHR . group Bwill be given highintensity exercise i.e skipping rope ( HR will be between 70-85%).
Receives: Other: high intensity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stroop test for Cognitive Function

    The Stroop Color and Word Test, interference on reading ability through three sections: word page, color page, and word-color page, each containing 5 columns with 20 items. In a 45-second timeframe, participants rapidly read words or name ink colors. Overall, the Stroop test offers a comprehensive evaluation of cognitive abilities related to interference and reading skills.

    Measured: 8 weeks

  2. Pittsburg sleep quality index ,

    Each of the seven component scores, encompassing subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction, is assigned a value on a scale ranging from 0 to 3. A score of 0 signifies an absence of difficulty, while a score of 3 reflects severe difficulty within the specific component. The calculation of the Global Pittsburgh Sleep Quality Index (PSQI) score involves summing up these seven component scores, resulting in a total score that ranges from 0 to 21. Elevated global scores are indicative of lower sleep quality, and a score exceeding 5 is generally construed as suggestive of poor sleep. In terms of interpretation, a global PSQI score falling between 0 and 5 is considered representative of "good" sleep quality, while a score surpassing 5 implies a lower quality of sleep.

    Measured: 8 weeks

  3. Digit span test

    The Digit Span Test gauges short-term memory and attention span by having individuals repeat digit sequences in the same or reverse order. Scores are assigned per correctly repeated digit, with the test progressively increasing in difficulty. The total score reflects the longest accurately recalled sequences in both conditions. Interpretation reveals insights into working memory and attentional control, where a higher Digit Span Forward score signifies efficient short-term memory, while a higher Digit Span Backward score indicates superior working memory and cognitive flexibility in recalling and manipulating sequences in reverse order.

    Measured: 8 weeks

  4. Sleep quality scale

    The Sleep Quality Scale (SQS) measures sleep quality in people who live in the general population.

    Using a four-point, Likert-type scale, respondents indicate how frequently they exhibit certain sleep behaviors (0 = "few," 1 = "sometimes," 2 = "often," and 3 = "almost always"). Scores on items belong to factors 2 and 5 (restoration after sleep and satisfaction with sleep) and are reversed before being tallied. Total scores can range from 0 to 84, with higher scores demoting more acute sleep problems.

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2024
  2. Study start1 Aug 2023
  3. Primary completion15 Mar 2024 (estimated)
  4. Study completionMay 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06230094
Sponsor's protocol ID
014244 tabinda
Status last verified
Jan 2024
First submitted
24 Nov 2023
Last updated
30 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing moderate intensity and high intensity in people with Sleep and Cognition, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Waqae Awan, PHD (0333-534884, waqar.ahmed@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stroop test for Cognitive Function (time frame: 8 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in